Program
Bismuth
Also written as “Bismuth Potassium Citrate Capsules”.
Its studies are led by 4 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| HK inno.N | 10 open or running | phase 1since Aug 20, 2019 | Aug 20, 2019 | none ahead |
| Jiangsu Sinorda Biomedicine | 10 open or running | phase 1since Sep 4, 2025 | Sep 4, 2025 | none ahead |
| Shandong Luoxin Pharmaceutical Group Stock | 10 open or running | phase 1since Jun 2, 2023 | Jun 2, 2023 | none ahead |
| Sihuan Pharmaceutical Holdings Group | 10 open or running | phase 1since May 15, 2020 | May 15, 2020 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Aug 20, 2019First study: phase 1 study in HealthyNew to HK inno.NHK inno.N · NCT04066257 · 32 enrolled · Korea, Republic of
- May 15, 2020Sihuan Pharmaceutical Holdings Group's first study: phase 1 study in Healthy Male VolunteersNew to Sihuan Pharmaceutical Holdings GroupSihuan Pharmaceutical Holdings Group · NCT04444011 · 32 enrolled
- Jun 2, 2023Shandong Luoxin Pharmaceutical Group Stock's first study: phase 1 study in HealthyNew to Shandong Luoxin Pharmaceutical Group StockShandong Luoxin Pharmaceutical Group Stock · NCT05915871 · 22 enrolled · China
- Sep 4, 2025Jiangsu Sinorda Biomedicine's first study: phase 1 study in Healthy VolunteersNew to Jiangsu Sinorda BiomedicineJiangsu Sinorda Biomedicine · NCT07294846 · 56 enrolled · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07294846Healthy Volunteers · China | 1 | Completed | Jiangsu Sinorda Biomedicine | Dec 15, 2025 | 56 |
| NCT05915871Healthy · China | 1 | Completed | Shandong Luoxin Pharmaceutical Group Stock | Apr 28, 2023 | 22 |
| NCT04444011Healthy Male Volunteers | 1 | UNKNOWN | Sihuan Pharmaceutical Holdings Group | Sep 30, 2020 | 32 |
| NCT04066257Healthy · Korea, Republic of | 1 | Completed | HK inno.N | Feb 22, 2019 | 32 |
How it is read
Names in the registry
- “Bismuth”, 3 entries
- “Bismuth Potassium Citrate Capsules”, 1 entry
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.